Director/PDMR Shareholding | 27-Mar-2025 | 09:53 | RNS |
Additional Listing | 25-Mar-2025 | 13:50 | RNS |
Trading Update | 25-Mar-2025 | 07:00 | RNS |
Holding(s) in Company | 24-Mar-2025 | 16:32 | RNS |
Annual Financial Report | 20-Mar-2025 | 14:08 | RNS |
Director/PDMR Shareholding | 14-Mar-2025 | 11:14 | RNS |
Director/PDMR Shareholding | 07-Mar-2025 | 13:33 | RNS |
Director/PDMR Shareholding | 07-Mar-2025 | 13:26 | RNS |
Director/PDMR Shareholding | 06-Mar-2025 | 16:42 | RNS |
Director/PDMR Shareholding | 06-Mar-2025 | 16:38 | RNS |
Director/PDMR Shareholding | 05-Mar-2025 | 08:56 | RNS |
Total Voting Rights | 03-Mar-2025 | 09:41 | RNS |
Results for the Full Year Ended 31 December 2024 | 26-Feb-2025 | 07:00 | RNS |
Holding(s) in Company | 19-Feb-2025 | 15:20 | RNS |
Appointment of Joint Corporate Broker | 11-Feb-2025 | 12:00 | RNS |
Currency | UK Pounds |
Share Price | 3,380.00p |
Change Today | 15.00p |
% Change | 0.45 % |
52 Week High | 3,955.00p |
52 Week Low | 2,230.00p |
Volume | 77,757 |
Shares Issued | 48.01m |
Market Cap | £1,622.75m |
RiskGrade | 151 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 3 |
Buy | 3 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 7 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 24-Apr-25 | 03-Oct-24 |
Paid | 15-May-25 | 24-Oct-24 |
Amount | 90.00p | 41.50p |
Time | Volume / Share Price |
16:35 | 30,955 @ 3,380.00p |
16:35 | 607 @ 3,380.00p |
16:35 | 447 @ 3,380.00p |
16:35 | 305 @ 3,380.00p |
16:35 | 77 @ 3,380.00p |
CEO | John Christopher Morgan |
CFO | Kelly Gangotra |
You are here: research